Clinical trial Recruiting at 1 site Observational Ages 18 to 60 Women only

Follow-up on Euromi silicone gel breast implants

Official title: Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants

Run by Euromi Biosciences · NCT05987475 · Data updated 2026-11-12

This study is tracking patients with Euromi silicone gel breast implants for 10 years to see how safe and effective they are and to check for any problems like implant rupture.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexWomen only
Enrollment177 (estimated)
SponsorEuromi Biosciences
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Nancy)
StatusRecruiting
StartedOctober 18, 2023
Main results expectedSeptember 2034
Study endsSeptember 2034
Registry record updatedNovember 29, 2023
Trial IDNCT05987475 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are females aged 18 to 60 who are undergoing breast reconstruction after mastectomy or aesthetic breast surgery and are willing to participate in a long-term follow-up.

Probably not a fit

Patients who are pregnant, breastfeeding, or have certain medical conditions such as diabetes or a high body mass index may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to conduct a prospective clinical follow-up of patients receiving Euromi Biosciences silicone gel-filled breast implants. It focuses on monitoring the long-term outcomes and potential complications associated with these implants, particularly breast implant rupture. Participants will be followed for a period of 10 years to gather data on the safety and effectiveness of the implants in breast reconstruction and aesthetic surgery settings.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term safety and performance of silicone gel breast implants, improving patient outcomes.

How similar studies have gone: While observational studies on breast implants are common, the specific focus on Euromi Biosciences implants may provide novel insights, as similar studies have shown varying results in terms of safety and complications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female;
* 18 years old and above, and under 60 years old;
* has approved and signed the informed consent form;
* eligible to receive at least one EUROMI Biosciences implant during breast reconstruction following a mastectomy or during aesthetic breast surgery;
* Willing to be followed up for a period of 10 years.

Exclusion Criteria:

* Informed pregnancy or breastfeeding at the time of inclusion
* Known hypersensitivity and / or allergy to silicone;
* Not understanding or not accepting the risks of further surgeries during follow-up;
* Body mass index \> 40 kg/m²;
* Diabetes
* HbA1c levels \> 7,5%;
* History of repeated failure with the implantation of similar implants;
* Tissue or fat insufficiency;
* Progressive breast cancer large tumours (\>5 cm), late cancer stage and deep tumours;
* Grossly positive axillary involvement / or chest wall involvement;
* High risk of cancer recurrence;
* Tissue damage in the implant area due to irradiation of the thoracic wall;
* Pre-existing pathology in the implant area;
* General infection or infection in the implant area;
* Medical condition (poor physiological condition, psychological instability, severe smoking, obesity, coagulopathy, diabetes, severe cardiovascular or pulmonary disease, etc.) Which may, according to the judgement of the surgeon, entail excessive risk and/or post-surgical complications;
* History or presence of an autoimmune disease;
* Immunocompromised;
* History or current treatment using radiation with lower-pole scarring and thin, poorly vascularized skin/tissue / microwave diathermy / or steroids;
* Medical condition likely to interfere with her capacity to understand the follow-up requirements, to participate in the follow-up or to give her informed consent;
* Concomitantly part of another interventional clinical trial.
* Under supervision or legal guardianship
* Deprived of liberty by a judicial or administrative decision
* Not affiliated to health insurance system or is a beneficiary of such coverage

Where it's running

  • CHRU Nancy
    Nancy, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.